Project Grant HT94252510467
Award Date
6/15/25
Completion Date
6/14/28
Dollars Obligated
$780K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Washington, DC 20057, USA
Similar Awards
Georgetown University received a $971,537 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on April 1, 2024, will support research to target cellular senescence and prevent post-traumatic epilepsy. The project will be conducted at Georgetown's facility in Washington, D.C. and is scheduled for completion by March 31, 2027. The Military Medical Research and Development program funds a...
The Defense Health Agency awarded Georgetown University a $378,144 Project Grant under the Military Medical Research and Development program (CFDA 12.420) for the period of May 1, 2023 through April 30, 2025. The grant will support research into genomics and biophysical strategies to overcome cisplatin resistance in ovarian cancer. The Military Medical Research and Development program aims to transform military and public health through innovative biomedical research, including investigating...
The U.S. Department of the Army Medical Command awarded a $322,000 Project Grant to Duke University under the Military Medical Research and Development program (CFDA 12.420) to conduct research on paternal preconception toxic exposure and autism risk. The research project, with a performance period from July 1, 2025 to June 30, 2027, will explore innovative approaches to preventing, diagnosing, and managing conditions relevant to military personnel and the broader public. Duke University, as a...
The federal Project Grant award of $6,663,794.00, awarded on September 30, 2024 by the Defense Health Agency, supports the "PRECISIE RTD TRIAL: PRECISION WITH RETURN-TO-DUTY DECISIONS IN THE MILITARY" research initiative under the Military Medical Research and Development (CFDA 12.420) program. This grant will fund advanced biomedical research focused on transforming healthcare for military service members, with a particular emphasis on conditions relevant to military personnel and...
The U.S. Defense Health Agency awarded a $624,000 Project Grant to Georgetown University under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "TARGETING OVARIAN STROMAL CELL SENESCENCE TO MITIGATE IR-INDUCED TRANSGENERATIONAL GASTROINTESTINAL CANCER RISK." The grant, with a performance period from July 1, 2024 to June 30, 2026, will support Georgetown's scientific investigation into developing treatments to address the increased risk of...
The U.S. Department of the Army Medical Command awarded a $2,027,311 Project Grant to The Trustees of the University of Pennsylvania (CFDA 12.420 - Military Medical Research and Development) for the "Army-Suicide Prevention Research on Implementation in the National Guard" program. This 4-year award, running from September 1, 2024 to August 31, 2028, will support advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader...
This $729,778 federal Project Grant award, issued by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports multiomic analysis of liquid biopsies for biomarker discovery and therapeutic targeting. The 3-year award to the University of Wisconsin System, which commenced on June 1, 2025, will fund advanced research into transforming healthcare for military service members and the broader public through innovative scientific investigations...
This federal Project Grant award, valued at $1,030,660.00, was issued by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. The primary awardee, The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., will conduct scientific investigations spanning basic, applied, and...
The Department of the Army Medical Command awarded Yale University a $738,509 Project Grant under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research into "THE ROLE OF TLR7/8-ACTIVATING MICRORNAS IN OBSTETRIC ANTIPHOSPHOLIPID SYNDROME" from September 30, 2021 to September 29, 2025. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming military and...
The federal Project Grant award in the amount of $2,402,721.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports the development of a patient monitoring and decision-support platform for precision health initiatives. The award was made to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., a non-profit organization that specializes in providing medical research, education, and...